TIL therapy is successfully treating some Siteman Cancer Center patients with metastatic melanoma HEC Science & Technology 5:35 4 days ago 251 Далее Скачать
HDAC8: a novel therapeutic target in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:42 2 years ago 57 Далее Скачать
Dr. Yee on Phase II ADAPT Trial Results for HER2+/HR+ Breast Cancer OncLive 1:19 9 years ago 233 Далее Скачать
HER2+ Cancer Treatment - Resistance, Immunologic Implications, and Biosimilars PracticeUpdate 4:27 4 years ago 5 Далее Скачать